HF
LXRX icon

HRT Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

HRT Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-122,780
Closed -$191K – 4874
2026
Q1 		$191K Buy
122,780
+5,231
+4% +$7.61K ﹤0.01% 3210
2025
Q4 		$135K Buy
117,549
+71,102
+153% +$97.7K ﹤0.01% 2729
2025
Q3 		$62K Sell
46,447
-442,021
-90% -$502K ﹤0.01% 2574
2025
Q2 		$461K Buy
+488,468
New +$316K ﹤0.01% 1649
2024
Q2 		– Sell
-16,965
Closed -$40K – 2719
2024
Q1 		$40K Buy
+16,965
New +$36.4K ﹤0.01% 1951
2023
Q3 		– Sell
-198,676
Closed -$454K – 2801
2023
Q2 		$454K Buy
+198,676
New +$527K ﹤0.01% 1405
2022
Q4 		– Sell
-45,569
Closed -$109K – 2850
2022
Q3 		$109K Buy
+45,569
New +$126K ﹤0.01% 2375
2022
Q2 		– Sell
-242,211
Closed -$506K – 3368
2022
Q1 		$506K Buy
242,211
+140,650
+138% +$390K ﹤0.01% 1627
2021
Q4 		$400K Buy
+101,561
New +$493K ﹤0.01% 2070
2020
Q3 		– Sell
-31,562
Closed -$62K – 2167
2020
Q2 		$62K Buy
+31,562
New +$61.8K ﹤0.01% 1299
2019
Q4 		– Sell
-16,364
Closed -$49K – 1440
2019
Q3 		$49K Buy
+16,364
New +$50.7K ﹤0.01% 1303

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRT Financial's LXRX Position: Q2 2026 in Review

HRT Financial sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 122,780 shares — an estimated $191K sold.

HRT Financial first reported a position in LXRX in Q3 2019 and held it in 11 quarters. The position peaked at $506K in Q1 2022. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • HRT Financial reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 122,780 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $191K.
  • HRT Financial first reported a position in Lexicon Pharmaceuticals in Q3 2019 and held it in 11 quarters.
  • HRT Financial's Lexicon Pharmaceuticals position peaked at $506K in Q1 2022.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.